Steven advises on mergers and acquisitions transactions for a wide range of commercial, government, energy and resources, pharmaceutical, wholesaling and professional services industry clients. Steven's areas of expertise include drafting and reviewing commercial contracts, corporate governance and trust law and superannuation compliance issues.
Advising the founders of the Camp Australia group on their sale to Bain Capital for an undisclosed amount reported at over $400 million.
Acting for the founding shareholders of Australia's leading supplier of pharmacy services to private hospital, oncology day clinics, IVF clinics and forensic facilities on the sale to Blue Sky Private Equity and then their subsequent divestment to EBOS Limited.
An Australasian-based diversified infrastructure business – acting in a number of supply-chain acquisitions in the civil construction sector.
Acting for French firm Bouygues Construction on its acquisition of leading Australian construction and fitout business, AW Edwards for an undisclosed transaction value.
Providing ongoing advice to Atomos Limited on their journey from private company conducting its Series A raise through to recent ASX listing and first UK acquisition.
Maddocks advises global pharma company on acquisition of Southern Cross Pharma
Maddocks has advised Lupin Limited and its subsidiary Generic Health on the acquisition of Southern Cross Pharma,
Maddocks advises BWX on acquisition of Flora and Fauna
Maddocks has advised ASX-listed wellness business BWX on its acquisition of Flora & Fauna
Active ingredient prescribing rules rolled out
As of 1 February 2021, it became mandatory for prescribers to prescribe most medicines by their respective active...
Competition law issues in the merger of Mylan and Pfizer’s Upjohn division
The competition law issues arising in the merger of Mylan and Pfizer’s Upjohn division.